Study will monitor weight loss and metabolic indicators for subjects in multi-center, single arm trial.
Multi-Center, Open-label Pilot Study to Evaluate the Safety and Effectiveness of the GI Windows Single Neodymium Magnet Anastomosis Procedure When Used to Create a Duodenal-Ileal Diversion with a Sleeve Gastrectomy (SNAP-S) for Subjects with Obesity and Type 2 Diabetes Mellitus (T2DM)
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
18
The SFM will be placed using an endoscope in the duodenum and laparoscopically into the ileum. A compression anastomosis will be created in each of the subjects and the diversion of enteral flow from the duodenum to ileum will create a metabolic effect that will induce weight loss and impact Type 2 Diabetes. Following the diversion being created, a gastric sleeve will be created according to standard technique.
QEII Health Sciences Centre
Halifax, Nova Scotia, Canada
Université Laval
Québec, Quebec, Canada
Weight Loss
Weight loss measured as a percent of total body weight (TBW)
Time frame: 12 months
Percent Responders
Percent responders; i.e. percent of subjects losing at least 10% TBW
Time frame: 12 months
Excess Weight Loss Measures
Excess weight loss (EWL)
Time frame: 12 months
Absolute Weight Loss Measures
Absolute weight loss
Time frame: 12 months
BMI - Weight Loss Measures
Change in BMI
Time frame: 12 months
Fasting Glucose
Mean change in fasting glucose
Time frame: 12 months
Hemoglobin A1c
Mean change in Hemoglobin A1c
Time frame: 12 months
Diabetes Remission and/or Improvements
Proportion of subjects experiencing diabetes remission and/or improvements
Time frame: 12 months
Diabetes Medication Dosage and Frequency Changes
Mean change in the dosage and frequency of diabetes medications from baseline
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Serum Lipids
Mean change in serum lipids
Time frame: 12 months
Blood Pressure Changes
Mean percent change in systolic/diastolic blood pressure
Time frame: 12 months
Liver Changes using Fibroscan
Change in Controlled Attenuation Parameter (CAP) Scores from baseline
Time frame: 12 months
Nutritional Status
Nutritional Status: changes in pre-albumin levels
Time frame: 12 months
Albumin - Nutritional Status
Nutritional Status: changes in albumin levels
Time frame: 12 months